Lab mates sending e transfers 🤣 #invivothings

Online Now: Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma dlvr.it/ScZj3F

Thanks to everyone who could make it out for our All Members Meeting and Social tonight! Highlights included a roundtable discussion on institutional funding for MD-PhD programs, new friends, and yummy cocktails 🥂 Who's excited for tomorrow's #AJM2022 program??

Day 2 of #AJM2022 is off to a Strong start with our keynote lecture by the President of CIHR 💪 unpacking some of the key issues shaping the Canadian funding landscape!

Grateful to have learned from such seasoned professionals in the world of #science #medicine #WomenInSTEM glad to see the knowledge dissemination between #mdphd generations 🤩

Online Now: Revealing de novo pyrimidine synthesis as a key vulnerability in brain tumors dlvr.it/SdJcgl

Pediatric #medulloblastoma (MB) is the most common malignant 🧠 brain #neoplasm. Dr. Sheila Singh (Sheila Singh Brain Tumour Lab) and the team at McMaster University characterize a protein interactome, providing valuable resources for therapeutic targeting! 🎯 Nature Communications | go.nature.com/3Hg6SFQ

Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma dlvr.it/SfNVvt

We are fundraising for this Sunday's Brain Tumor Walk for the Brain Tumor Foundation of Canada! Please consider donating at the following link, and sharing this post to spread the word - we thank you for your support! shorturl.at/bhw46

📣📣We're back again with our CIP the T  (career information for physician-scientist trainees) series! If you had any questions or intentions on pursuing a career as a surgeon-scientist be sure to join us on October 30th at 3:00PM EST for a chance to learn from surgeon-scientists

This fall, we’re hosting a glioblastoma workshop with The Sontag Foundation, led by William Kaelin of Dana-Farber, Sheila Singh of McMaster University & Timothy Cloughesy of UCLA. Participants will pool insights to hone in on promising new research directions. #GlioblastomaAwarenessDay #GBMDay

We are thrilled to share our latest research on "Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells" published in Nature Medicine, led by former PhD student Dr. Chirayu Chokshi Chirayu Chokshi McMaster Health Sciences #glioblastoma #McMaster rdcu.be/dPLrp

A team of Canadian and American researchers co-led by Sheila Singh Brain Tumour Lab and The Hospital for Sick Children (SickKids) have developed a promising therapy treatment that can kill glioblastoma cells in newly discovered pathway. CIHR NRC Canada UVA University of Pittsburgh Princess Margaret Cancer Centre ow.ly/XWbz50SQ4H9

Want to join our program? Applications for the McMaster MD/PhD program are open until November 1st, 2024.

Excited to announce I finally defended my PhD in Sheila Singh Brain Tumour Lab! After raising a husky, facing the COVID lockdown, planning 6 medical/graduate/high school student conferences and seminars, performing a visiting research scholar internship at Stanford University, creating brand new CAR T

📢 Join our #CIPtheT seminar: "Aligning Research & Medicine" 🩺🔬 📅 Dec 5, 2024 | 🕐 1 PM EST Hear from resident physician scientists on balancing clinical & research careers. 🔗 Register: forms.gle/zXY2axbKL1QMZ7… 📩 Questions? Email us at [email protected].

🎉 Save the Date! The 2025 CSCI-CITAC-CIP Annual Joint Meeting is happening in Toronto on April 9-10, 2025, at the DoubleTree Hilton. Don't miss this incredible opportunity to discuss research, network, and learn! Details: event.fourwaves.com/c23aad0e-d0ed-…

A new genome-wide #CRISPR screen identifies BACE1 as a driver of lung cancer #metastasis to the brain, suggesting that BACE1 inhibitors could be repurposed to prevent brain metastasis in #NSCLC. Sheila Singh Brain Tumour Lab McMaster Surgery scim.ag/4eyJwtG